Awarded

TENECTEPLAZUM-PULB. + SOLV. PT. SOL. INJ.-5mg/ml (1000 U/ml) - 10000 U

Name: TENECTEPLAZUM-PULB. + SOLV. PT. SOL. INJ.-5mg/ml (1000 U/ml) - 10000 U
Creator: SPITALUL ORASENESC NEGRESTI OAS
Published: 2026-09-15
License: https://ted.europa.eu/en/simap/legal-notice

Track this recordFree account — get alerted when a contract here runs out.

Buyer: SPITALUL ORASENESC NEGRESTI OAS
Winners: BIOEEL, DR.MAX, FARMEXIM S.A.
Contract value: RON 346,264
Bids received: 4
Published: 15 Sept 2026
Awarded: 8 Dec 2025
Contract start: 8 Dec 2025
Contract end: 9 Dec 2026estimated
Sector: Medical equipment and pharmaceuticals
Region: Satu Mare
Source: Original notice on TED (638243-2026)

More awards from this buyer

Awarded	Buyer	Winner	Contract value	Published
TRASTUZUMABUM - pulb. pt. conc. pt. sol perf. - 150 mg	SPITALUL ORASENESC NEGRESTI OAS	DONA. LOGISTICA, FILDAS TRADING, MEDIPLUS EXIM SRL	RON 156,752	15 Sept 2026
PANITUMUMABUM - conc. pt. sol. perf. 20mg/ml - 100 mg - 5 ml	SPITALUL ORASENESC NEGRESTI OAS	ALLIANCE HEALTHCARE ROMANIA, FILDAS TRADING, MEDIPLUS EXIM SRL	RON 458,714	15 Sept 2026
AVELUMABUM - conc. pt. Sol. Perf. - 20mg/ml - 10ml	SPITALUL ORASENESC NEGRESTI OAS	FARMEXIM S.A., MEDIPLUS EXIM SRL	RON 3,344,848	15 Sept 2026
DURVALUMABUM - conc.pt.sol.perf. 50 mg/ml - (500mg) - 10 ml	SPITALUL ORASENESC NEGRESTI OAS	ALLIANCE HEALTHCARE ROMANIA, FARMEXIM S.A., MEDIPLUS EXIM SRL	RON 3,507,625	15 Sept 2026
DOXORUBICINUM - conc. pt. sol. perf. 2 mg/ml - 10 ml (caelyx)	SPITALUL ORASENESC NEGRESTI OAS	ALLIANCE HEALTHCARE ROMANIA	RON 61,889	15 Sept 2026
DURVALUMABUM - conc.pt.sol.perf. 50 mg/ml - (120mg) - 2,4 ml	SPITALUL ORASENESC NEGRESTI OAS	ALLIANCE HEALTHCARE ROMANIA, FARMEXIM S.A., MEDIPLUS EXIM SRL	RON 842,722	15 Sept 2026